150 related articles for article (PubMed ID: 15930360)
21. Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents.
Holden SA; Lan Y; Pardo AM; Wesolowski JS; Gillies SD
Clin Cancer Res; 2001 Sep; 7(9):2862-9. PubMed ID: 11555604
[TBL] [Abstract][Full Text] [Related]
22. ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity.
Wei J; Chen X; Li Q; Chen J; Khan N; Wang B; Cheng JW; Gordon JR; Li F
Oncol Rep; 2014 Apr; 31(4):1599-604. PubMed ID: 24482222
[TBL] [Abstract][Full Text] [Related]
23. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
[TBL] [Abstract][Full Text] [Related]
25. In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.
Iigo M; Sakurai M; Tamura T; Saijo N; Hoshi A
Cancer Res; 1988 Jan; 48(2):260-4. PubMed ID: 2446744
[TBL] [Abstract][Full Text] [Related]
26. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
Yang X; Chu Y; Wang Y; Zhang R; Xiong S
J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
[TBL] [Abstract][Full Text] [Related]
27. Combination of copper-chelating agent, trientine, and methotrexate attenuates colorectal carcinoma development and angiogenesis in mice.
Yoshiji H; Yoshii J; Kuriyama S; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Kitade M; Yamazaki M; Fukui H
Oncol Rep; 2005 Jul; 14(1):213-8. PubMed ID: 15944792
[TBL] [Abstract][Full Text] [Related]
28. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
[TBL] [Abstract][Full Text] [Related]
29. Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin.
Cai KX; Tse LY; Leung C; Tam PK; Xu R; Sham MH
Clin Cancer Res; 2008 Feb; 14(3):939-49. PubMed ID: 18245558
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB
Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760
[TBL] [Abstract][Full Text] [Related]
31. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY
Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030
[TBL] [Abstract][Full Text] [Related]
32. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.
Xiao F; Wei Y; Yang L; Zhao X; Tian L; Ding Z; Yuan S; Lou Y; Liu F; Wen Y; Li J; Deng H; Kang B; Mao Y; Lei S; He Q; Su J; Lu Y; Niu T; Hou J; Huang MJ
Gene Ther; 2002 Sep; 9(18):1207-13. PubMed ID: 12215887
[TBL] [Abstract][Full Text] [Related]
33. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Hu-Lowe DD; Zou HY; Grazzini ML; Hallin ME; Wickman GR; Amundson K; Chen JH; Rewolinski DA; Yamazaki S; Wu EY; McTigue MA; Murray BW; Kania RS; O'Connor P; Shalinsky DR; Bender SL
Clin Cancer Res; 2008 Nov; 14(22):7272-83. PubMed ID: 19010843
[TBL] [Abstract][Full Text] [Related]
34. Interstitial wires releasing diffusing alpha emitters combined with chemotherapy improved local tumor control and survival in squamous cell carcinoma-bearing mice.
Cooks T; Arazi L; Efrati M; Schmidt M; Marshak G; Kelson I; Keisari Y
Cancer; 2009 Apr; 115(8):1791-801. PubMed ID: 19197995
[TBL] [Abstract][Full Text] [Related]
35. Combination of vesicular stomatitis virus matrix protein gene therapy with low-dose cisplatin improves therapeutic efficacy against murine melonoma.
Luo S; Chen P; Luo ZC; Zhang P; Sun P; Shi W; Li ZY; Zhang XL; Wang LQ; Chen X; Wei YQ; Wen YJ
Cancer Sci; 2010 May; 101(5):1219-25. PubMed ID: 20331624
[TBL] [Abstract][Full Text] [Related]
36. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
37. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].
Gao ZQ; Han BH; Sha HF; Shi ZY; Yang XH; Feng JX
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461
[TBL] [Abstract][Full Text] [Related]
38. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
[TBL] [Abstract][Full Text] [Related]
39. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model.
Sigounas G; Sallah S; Sigounas VY
Cancer Lett; 2004 Oct; 214(2):171-9. PubMed ID: 15363543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]